leucopenia after chemotherapy
Conditions
Interventions
Sponsors
The Third Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
50 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Ovarian epithelial serous adenocarcinoma or mucinous adenocarcinoma confirmed by histopathology or cytopathology, with stages II-III; 2. Chemotherapy regimen: paclitaxel 175 mg/m^2, intravenous drip > 3 h; carboplatin AUC 5-6 intravenous drip > 1 h; repeated every 3 weeks; 3. Aged 50 to 65 years old; 4. the physical condition of the subjects is acceptable, and the Karnofsky score is more than 80 points; 5. the degree of bone marrow suppression: Grade II: white blood cells (2 ~ 2.9) x 10^9/L; 6. the subjects agreed well and agreed to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. leucopenia caused by other causes; 2. pregnant and intentional pregnancy or lactation women; 3. combined with severe heart, liver, spleen, lung, kidney, bone and other important organ damage; 4. those with cognitive impairment or severe mental illness; 5. patients with hematological diseases; 6. patients with autoimmune diseases; 7. those with severe infection or chronic infectious diseases; 8. those who use other myelosuppressive drugs or leukocytosis drugs during the treatment; 9. those who had received moxibustion treatment within 1 months before participating in the study; 10. participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune Repertoire sequencing; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lymphocyte Subgroup Classification;complete blood count; | — |
Countries
China
Contacts
Public ContactJinchang Huang
Beijing University of Chinese Medicine
Outcome results
None listed